Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
7.33
0.73 (11.06%)
At close: Aug 15, 2025, 3:59 PM
7.56
3.21%
After-hours: Aug 15, 2025, 07:56 PM EDT

Kura Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-197.17M -181.89M -173.98M -197.55M -181.75M -168.09M -152.63M -142.96M -139.86M -137.46M -135.84M -135.47M -133.33M -132.22M -130.47M -123.88M -114.28M -101.11M
Depreciation & Amortization
-11.9M -9.4M -9.41M -9.4M 866K 877K 849K 841K 818K 788K 759K 719K 686K 627K 558K 500K 414K 302K
Stock-Based Compensation
31.75M 33.23M 33.9M 32.43M 31.2M 29.76M 28.08M 27.72M 26.98M 26.51M 26.32M 25.91M 25.67M 25.15M 23.58M 20.92M 18.17M 14.73M
Other Working Capital
282.53M 304.82M 270.97M -2.52M -1.47M -2.39M -2.51M -3.21M -3.09M -2.79M -3.28M 5.47M 5.56M 746K 746K -2.95M -1.06M 4.42M
Other Non-Cash Items
5.73M 2.17M 1.55M -3.32M -14.06M -10.52M -8.94M -1.91M 4.69M 5.36M 8.03M 9.83M 4.3M 5.25M 5M 4.15M 3.14M 1.38M
Deferred Income Tax
n/a n/a n/a 5M 2.11M n/a n/a -5M -2.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
296.58M 267.12M 282.26M 3.71M 6.93M 10.18M 7.82M 4.26M 6.8M -2.6M -2.98M -1.54M -7.8M -7.02M -3.22M -1.19M 694K 6.18M
Operating Cash Flow
124.99M 111.23M 134.32M -169.12M -154.71M -137.8M -124.82M -117.05M -109.03M -113.75M -110.06M -106.9M -110.48M -108.22M -104.55M -99.49M -91.86M -78.53M
Capital Expenditures
-2.12M -680K -472K -116K -136K -216K -168K -164K -525K -613K -626K -716K -1.06M -1.17M -1.15M -1.32M -1.26M -1.69M
Cash Acquisitions
n/a n/a n/a -26.49K -35.06K 11.16K n/a 73.79K 82.37K 2.86K 14.03K -33.28K -33.28K n/a n/a n/a n/a n/a
Purchase of Investments
-685.63M -732.7M -659.05M -518.15M -553.1M -531.05M -409.82M -416.26M -376.54M -293.09M -270.65M -180.87M -200.15M -273.9M -445.66M -557.34M -577.23M -532.85M
Sales Maturities Of Investments
595.86M 625.72M 557.93M 553.83M 551.82M 440.36M 425.55M 342.47M 366.36M 362.42M 303.91M 335.59M 305.95M 309.49M 319.97M 297.57M 249.34M 220.92M
Other Investing Acitivies
n/a n/a n/a 26.49K 35.06K -11.16K n/a -73.79K 72.11M 72.19M 47.26M 121.47M 72.55M 35.59M -125.69M -259.77M -327.89M -311.93M
Investing Cash Flow
-91.89M -107.66M -101.59M 35.56M -1.42M -90.91M 15.56M -73.96M -10.71M 68.72M 32.63M 154.01M 104.74M 34.42M -126.83M -261.09M -329.15M -313.62M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 10M 10M 10M 10M n/a n/a -6.5M -7.25M -7.25M -7.25M -750K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 2.56M 2.56M 2.56M 2.99M 431K 25.14M 26.02M 28.26M 28.57M 4.65M 6.02M 3.29M 3.81M 5.72M 8.15M 145.58M
Financial Cash Flow
3.67M 6.19M 154.42M 154.3M 152.18M 243.15M 94.78M 128.81M 129.6M 38.26M 38.56M 4.65M 6.02M -3.21M -3.44M 322.81M 325.23M 469.17M
Net Cash Flow
36.77M 9.76M 187.14M 20.74M -3.94M 14.45M -14.48M -62.2M 9.87M -6.77M -38.87M 51.75M 283K -77M -234.82M -37.77M -95.78M 77.02M
Free Cash Flow
122.86M 110.55M 133.84M -169.24M -154.84M -138.01M -124.99M -117.21M -109.55M -114.37M -110.69M -107.61M -111.54M -109.38M -105.7M -100.81M -93.13M -80.22M